Aurora Cannabis Inc. (ACB) vs EyePoint Pharmaceuticals, Inc. (EYPT)

A side-by-side comparison of Aurora Cannabis Inc. and EyePoint Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACB vs EYPT

growth of $100 · dividends reinvested · last 10y
ACB -97.3% (-30.2%/yr)EYPT -89.5% (-20.2%/yr)EYPT compounded faster over this window
0200400600800Start $10020182020202220242026$3$10
ACB EYPT

ACB vs EYPT: by the numbers

  • •ACB is the larger company ($275M vs $259M market cap).
  • •Both run net losses; ACB's is the smaller (-38.13% vs -10994.73% net margin).
  • •ACB grew revenue faster over the past five years (1.68% vs -41.05% CAGR).

Metrics side by side

Valuation

MetricACBEYPT
P/S ratio1.3293.04
P/B ratio0.741.56

Profitability

MetricACBEYPT
Gross margin42.62%93.41%
Operating margin-14.55%-775.98%
Net margin-38.13%-10994.73%
ROE-21.41%-184.27%
ROIC-15.69%-170.19%

Growth (annualized)

MetricACBEYPT
Revenue CAGR (5Y)1.68%-41.05%
Total return CAGR (5Y)-42.83%-21.68%

Frequently asked

Which has grown faster, ACB or EYPT?
Over the past five years, ACB grew revenue faster — ACB at a 1.68% CAGR versus EYPT at -41.05%.
How have ACB and EYPT total returns compared?
Over the past 10 years, ACB delivered -30.23% and EYPT delivered -20.02% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.